Worksite intervention study to prevent diabetes in Nepal: a randomised trial protocol.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
08 2020
Historique:
received: 01 01 2020
revised: 03 07 2020
accepted: 06 07 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 22 12 2020
Statut: ppublish

Résumé

In Nepal, approximately 31% of adult industrial employees have diabetes. While the prevention of type 2 diabetes through behavioural intervention has been disseminated, worksite could be an effective platform for the translation of this knowledge into action as employed adults spend most of their workday waking hours at workplaces. We will conduct a randomised controlled trial to assess the effectiveness of a behavioural and a canteen intervention on diabetes risk reduction among those who are prediabetic at two worksites in eastern Nepal. We will recruit 162 adult full-time factory workers with haemoglobin A1c (HbA1c) of 5.7%-6.4% at baseline or fasting blood sugar of 100-125 mg/dL. The 8-14 months' control period will be followed by the behavioural intervention where half of the participants will be randomised to receive the behavioural intervention and half will act as a control and will not receive any intervention. Then, all participants will receive the canteen intervention. The analysis will be intent-to-treat, comparing the difference in the change in HbA1c% between the behavioural intervention group and the control group using a two-sample t-test. The within-participant changes in HbA1c after 6 or more months on the canteen intervention among those not randomised to the behavioural intervention in the previous period will be assessed using the paired t-test. Ethical approval was obtained from the Institutional Review Board at Yale School of Public Health, New Havens, USA and the Nepal Health Research Council. NCT04161937.

Identifiants

pubmed: 32847993
pii: openhrt-2019-001236
doi: 10.1136/openhrt-2019-001236
pmc: PMC7451278
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Banques de données

ClinicalTrials.gov
['NCT04161937']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : DP1 ES025459
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Natl Med J India. 2005 Mar-Apr;18(2):59-65
pubmed: 15981439
Heart Asia. 2017 Oct 26;9(2):e010956
pubmed: 29225703
Diabetes Care. 2011 May;34 Suppl 2:S210-4
pubmed: 21525457
J Occup Med Toxicol. 2016 May 14;11:25
pubmed: 27182279
Diabetes Manag (Lond). 2017;7(2):197-204
pubmed: 28794802
Metabolism. 2015 Feb;64(2):338-47
pubmed: 25467842
J Occup Health. 2018 Jan 25;60(1):31-45
pubmed: 29187673
Glob Health Action. 2015 Nov 26;8:29088
pubmed: 26613684
Occup Environ Med. 2004 Jul;61(7):643-8, 585
pubmed: 15208383
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
J Occup Environ Med. 2014 Oct;56(10):1052-61
pubmed: 25285827
Health Aff (Millwood). 2012 Jan;31(1):67-75
pubmed: 22232096
J Clin Lab Anal. 2012 Nov;26(6):481-5
pubmed: 23143632

Auteurs

Prajjwal Pyakurel (P)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal prazzwal@gmail.com.

Archana Shrestha (A)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Biraj M Karmacharya (BM)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Shyam S Budhathoki (SS)

Golden Community Hospital, Lalitpur, Nepal.

Rajendra Kumar Chaudhari (RK)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Dipesh Tamrakar (D)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Abha Shrestha (A)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Robin M Karmacharya (RM)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Anmol Shrestha (A)

Kathmandu University School of Medical Sciences, Kathmandu, Nepal.

Sumitra Sharma (S)

Kathmadnu Medical College Teaching Hospital, Kathmandu, Nepal.

Sanjib Kumar Sharma (SK)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Donna Spiegelman (D)

Yale School of Public Health, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH